Dolby Laboratories, Inc.
DLB
$72.38
$0.931.30%
NYSE
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 264.26M | 256.63M | 262.67M | 261.83M | 212.44M |
| Total Depreciation and Amortization | 98.41M | 95.21M | 91.56M | 87.33M | 87.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 96.02M | 87.20M | 89.03M | 84.70M | 109.47M |
| Change in Net Operating Assets | 6.86M | -19.93M | -17.64M | -106.60M | -113.01M |
| Cash from Operations | 465.54M | 419.11M | 425.62M | 327.25M | 296.10M |
| Capital Expenditure | -27.48M | -28.67M | -30.69M | -30.01M | -30.81M |
| Sale of Property, Plant, and Equipment | 16.88M | 16.88M | -- | -- | -- |
| Cash Acquisitions | -489.24M | -489.24M | -489.24M | -487.88M | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 249.86M | 249.73M | 224.86M | 231.59M | -13.88M |
| Cash from Investing | -249.98M | -251.30M | -295.07M | -286.29M | -44.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 39.40M | 36.98M | 44.06M | 40.93M | 50.76M |
| Repurchase of Common Stock | -147.05M | -142.23M | -131.95M | -199.08M | -204.95M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -123.62M | -120.69M | -117.58M | -114.58M | -111.79M |
| Other Financing Activities | -12.03M | -15.02M | -14.78M | -15.08M | -4.51M |
| Cash from Financing | -243.30M | -240.96M | -220.25M | -287.81M | -270.49M |
| Foreign Exchange rate Adjustments | 5.69M | -869.00K | -7.31M | 6.64M | -1.44M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.06M | -74.01M | -97.00M | -240.21M | -20.54M |